Cardiometabolic screening, elevated results and clinical follow-up actions in Māori and non-Māori with psychosis in Canterbury, Aotearoa New Zealand
Australian & New Zealand Journal of Psychiatry · 2026
DOI: 10.1177/00048674261461979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian & New Zealand Journal of Psychiatry, 2026. Verfasst von Nathan Monk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Mass Screening, Psychotic Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Objective
Estimate and compare rates of cardiometabolic blood screening, elevated results and clinical follow-up actions for Māori and non-Māori mental health service users with psychosis in Canterbury, Aotearoa New Zealand.
Methods
A retrospective cohort study ( N = 3840) with dynamic entry was conducted with people aged 18–64 years with a psychosis diagnosis in Canterbury Specialist Mental Health Service (1 August 2012 to 31 December 2019). Linked administrative data captured lipid and HbA1c screening within 1 year of study entry, elevated results (triglycerides > 2.2 mmol/L; total cholesterol:high-density lipoprotein cholesterol > 5; HbA1c > 40 mmol/mol) from individual study entry to 31 December 2023, and clinical actions (repeat test; statin/metformin dispensing) within 1 year following an elevated result.
Results
887/3840 (23%) of Canterbury Specialist Mental Health Service users with psychosis were Māori. First-year screening rates were modest (31–44%), similar by ethnicity and broadly higher among clozapine/olanzapine users. Māori had higher odds of both elevated lipids and HbA1c. About one-third of elevated results were followed up with re-testing within 1 year. Rates of follow-up testing and medication dispensing were broadly similar for Māori and non-Māori, except Māori were more likely to receive repeat HbA1c testing after an elevated result (odds ratio = 1.71 [1.16, 2.50]).
Conclusions
Findings highlight large gaps in cardiometabolic screening and follow-up actions among Māori and non-Māori Specialist Mental Health Service users with psychosis. Māori presented with psychosis 4 years younger, had significantly higher rates of elevated cardiometabolic risk markers and were more likely to receive HbA1c re-testing following an elevated result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
- Department of Māori/Indigenous Health Innovation, University of Otago, Christchurch, New Zealand.
- Specialist Mental Health Service, Health New Zealand - Canterbury (Te Whatu Ora - Waitaha), Christchurch, New Zealand.
- Population Health Gain, Service Improvement and Innovation, Health New Zealand - Canterbury (Te Whatu Ora - Waitaha), Christchurch, New Zealand.
- Department of Public Health, University of Otago, Wellington, New Zealand.
- Centre for Health and Social Practice, Waikato Institute of Technology, Hamilton, New Zealand.
ORCID-Profile: Nathan Monk, Emily Barrett, Mau Te Rangimarie Clark, Ruth Cunningham, Waikaremoana Waitoki, Richard Porter
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Monk, N., Barrett, E., Fitzjohn, J., Clark, M. T. R., Kerdemelidis, M., Cunningham, R., McLachlan, A., Waitoki, W., Porter, R., & Lacey, C. (2026). Cardiometabolic screening, elevated results and clinical follow-up actions in Māori and non-Māori with psychosis in Canterbury, Aotearoa New Zealand. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/00048674261461979
Vancouver
Monk N, Barrett E, Fitzjohn J, Clark MTR, Kerdemelidis M, Cunningham R, et al. Cardiometabolic screening, elevated results and clinical follow-up actions in Māori and non-Māori with psychosis in Canterbury, Aotearoa New Zealand. Australian & New Zealand Journal of Psychiatry. 2026. doi:10.1177/00048674261461979
BibTeX
@article{Monk2026,
author = {Monk, Nathan and Barrett, Emily and Fitzjohn, Julie and Clark, Mau Te Rangimarie and Kerdemelidis, Melissa and Cunningham, Ruth and McLachlan, Andre and Waitoki, Waikaremoana and Porter, Richard and Lacey, Cameron},
title = {Cardiometabolic screening, elevated results and clinical follow-up actions in Māori and non-Māori with psychosis in Canterbury, Aotearoa New Zealand},
journal = {Australian & New Zealand Journal of Psychiatry},
year = {2026},
doi = {10.1177/00048674261461979}
}
EUVIMED